Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature Infants
The Impact of Human-derived Human Milk Fortifiers (H2MF) on Gut Microbiota Development and Oxidative Stress in Premature Infants
Sponsor: Children's Hospital Foundation
A NA clinical study on Microbial Colonization and Oxidative Stress, this trial is completed. The trial is conducted by Children's Hospital Foundation and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2019 — Oct 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Nov 2018 — Jun 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Oct 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Foundation
- Manitoba Developmental Origins of Chronic Diseases in Children Network (DEVOTION)
- Prolacta Bioscience
- University of Manitoba
For direct contact, visit the study record on ClinicalTrials.gov .